Franklin Resources’s Albireo Pharma Inc ALBO Stock Holding History

Franklin Resources’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-925,070	Closed	-$20M	–	2422
2022 Q4	$20M	Sell	925,070 -234	-0%	-$4.95K	0.01%	775
2022 Q3	$17.9M	Buy	925,304 +52,406	+6%	+$1.08M	0.01%	792
2022 Q2	$17.3M	Buy	872,898 +394,595	+82%	+$10.4M	0.01%	822
2022 Q1	$14.3M	Buy	478,303 +174,151	+57%	+$5.1M	0.01%	935
2021 Q4	$7.08M	Buy	304,152 +32,845	+12%	+$873K	﹤0.01%	1141
2021 Q3	$8.46M	Hold	271,307	–	–	﹤0.01%	1094
2021 Q2	$9.54M	Buy	271,307 +21,300	+9%	+$693K	﹤0.01%	1014
2021 Q1	$8.81M	Hold	250,007	–	–	﹤0.01%	999
2020 Q4	$9.38M	Buy	250,007 +7	+0%	+$255	﹤0.01%	974
2020 Q3	$8.34M	Buy	+250,000	New	+$7.28M	﹤0.01%	952

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Franklin Resources's ALBO Position: Q1 2023 in Review

Franklin Resources sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 925,070 shares — an estimated $20M sold.

Franklin Resources first reported a position in ALBO in Q3 2020 and held it in 10 quarters. The position peaked at $20M in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Franklin Resources reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Franklin Resources sold 925,070 Albireo Pharma Inc shares in Q1 2023, an estimated $20M.
Franklin Resources first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 10 quarters.
Franklin Resources's Albireo Pharma Inc position peaked at $20M in Q4 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.